TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.81
0.04 (2.26%)
At close: Aug 14, 2025, 3:59 PM
1.98
9.39%
Pre-market: Aug 15, 2025, 04:07 AM EDT
TScan Therapeutics Revenue
TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending June 30, 2025, TScan Therapeutics generated $0 in revenue.
Revenue (ttm)
2.82M
Revenue Growth
-86.62%
Price / Sales Ratio
120.9
Revenue / Employee
14.08K
Employees
200
Market Cap
102.43M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|